PETER WONG: Open Payments
NPI 1942416284 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,134 in 76 payments from 16 companies in 2025. Trend: 2023 $1,972 · 2024 $2,074 · 2025 $2,134
Food & beverage: $2,134
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 12 | $479 |
| AstraZeneca Pharmaceuticals LP | 15 | $310 |
| Phathom Pharmaceuticals, Inc. | 2 | $248 |
| Amgen Inc. | 10 | $226 |
| Esperion Therapeutics, Inc. | 11 | $195 |
| Axsome Therapeutics, Inc. | 1 | $124 |
| Otsuka America Pharmaceutical, Inc. | 4 | $93 |
| Aimmune Therapeutics, Inc. | 5 | $88 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $75 |
| Lilly USA, LLC | 3 | $68 |
Products named: VOQUEZNA, NEXLETOL, BREZTRI, JARDIANCE, Vemlidy, Auvelity, EVENITY, REXULTI.
Industry payments across NY — which companies pay providers there.
